Schedule 13G ownership disclosure
Beam Therapeutics Inc
Security class unavailable · CUSIP: 07373V105
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,662,043
- Percent of class
- 8.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001086364-24-003822
- Form type
- SC 13G
- Filer
- Beam Therapeutics Inc.
- CIK
- CIK 1745999
- Filed
- Jan 25, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership